Hodgkin Disease Lymphoma
3 clinical trials · Condition
◉ Watch Hodgkin Disease Lymphoma
| Record | Firm | Date |
|---|---|---|
| A Phase III Study to Evaluate the Efficacy and Safety of Penpulimab in the Relapsed and Refractory Classical Hodgkin's Lymphoma (NCT05244642) | Akeso | 2022-02-15 |
Track Hodgkin Disease Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.